News & Announcements

ALS Initiative

This new initiative encourages innovative research to spur progress on a devastating neurological disease.

Gil Omenn FNIH Board of Directors

Dr. Omenn is the Harold T. Shapiro Distinguished University Professor of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics and Public Health and founding director of the Center for Computational Medicine & Bioinformatics at the University of Michigan at Ann Arbor.

A Plus Trial

This three-year study will assess whether a single oral dose of azithromycin is effective in preventing sepsis in pregnant women and their newborns in low- and middle-income countries.


FNIH Pandemic Response Fund

This fund was established in response to the inquiries to support the NIH and NIAID in their efforts to rapidly end the threat from COVID-19 and to prepare the United States to defend against future pandemics.

ACTIV Partnership

This partnership will develop an international strategy for a coordinated research response to the COVID-19 pandemic.


The milestone signals regulatory support to move forward in the biomarker qualification process, an important first step in developing non-invasive biomarkers for patients with NASH. 




Front Page: